These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27881006)

  • 61. The Effects of Nanoencapsulated Curcumin-Fe3O4 on Proliferation and hTERT Gene Expression in Lung Cancer Cells.
    Sadeghzadeh H; Pilehvar-Soltanahmadi Y; Akbarzadeh A; Dariushnejad H; Sanjarian F; Zarghami N
    Anticancer Agents Med Chem; 2017; 17(10):1363-1373. PubMed ID: 28270067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Massive Upper Gastrointestinal Bleeding Due to a Ruptured Splenic Artery Pseudoaneurysm.
    Salemis NS; Boubousis G; Lagoudianakis E
    Am Surg; 2016 Dec; 82(12):e338-340. PubMed ID: 28234162
    [No Abstract]   [Full Text] [Related]  

  • 63. Identification and Verification of Core Genes in Colorectal Cancer.
    Xu H; Ma Y; Zhang J; Gu J; Jing X; Lu S; Fu S; Huo J
    Biomed Res Int; 2020; 2020():8082697. PubMed ID: 32462020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. From odor to oncology: non-canonical odorant receptors in cancer.
    Park SJ; Greer PL; Lee N
    Oncogene; 2024 Jan; 43(5):304-318. PubMed ID: 38087050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hypomorphic variants of SEL1L-HRD1 ER-associated degradation are associated with neurodevelopmental disorders.
    Wang HH; Lin LL; Li ZJ; Wei X; Askander O; Cappuccio G; Hashem MO; Hubert L; Munnich A; Alqahtani M; Pang Q; Burmeister M; Lu Y; Poirier K; Besmond C; Sun S; Brunetti-Pierri N; Alkuraya FS; Qi L
    J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 37943610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of
    Hu HF; Wang Z; Tang WL; Fu XM; Kong XJ; Qiu YK; Xi SY
    Front Pharmacol; 2022; 13():1047507. PubMed ID: 36438804
    [No Abstract]   [Full Text] [Related]  

  • 68. An integrative transcriptome analysis reveals potential predictive, prognostic biomarkers and therapeutic targets in colorectal cancer.
    Samadi P; Soleimani M; Nouri F; Rahbarizadeh F; Najafi R; Jalali A
    BMC Cancer; 2022 Jul; 22(1):835. PubMed ID: 35907803
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comprehensive Analysis of Expression and Prognostic Value of MS4As in Glioma.
    Zeng Y; Tan P; Ren C; Gao L; Chen Y; Hu S; Tang N; Chen C; Du S
    Front Genet; 2022; 13():795844. PubMed ID: 35734424
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification and Validation of a Novel Six-Gene Prognostic Signature of Stem Cell Characteristic in Colon Cancer.
    Liang Y; Su Q; Wu X
    Front Oncol; 2020; 10():571655. PubMed ID: 33680915
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer.
    Han J; Zhang X; Liu Y; Jing L; Liu YB; Feng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32797167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distinct Expression and Prognostic Value of MS4A in Gastric Cancer.
    Sun L; Zhang Y; Zhang C
    Open Med (Wars); 2018; 13():178-188. PubMed ID: 29756054
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Decreased expression of MS4A12 inhibits differentiation and predicts early stage survival in colon cancer.
    He L; Deng HY; C Wang X
    Neoplasma; 2017; 64(1):65-73. PubMed ID: 27881006
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes.
    Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O
    Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2.
    Koslowski M; Türeci O; Huber C; Sahin U
    Mol Cancer; 2009 Sep; 8():77. PubMed ID: 19781065
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
    Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
    Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
    Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
    J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
    Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
    Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.